Development and validation of a stability-indicating UHPLC–MS/MS method for simultaneous quantification of bupropion, hydroxybupropion, sertraline and desmethylsertraline: application to forced degradation studies
Background: Bupropion and sertraline, together with their major metabolites hydroxybupropion and desmethylsertraline, require reliable simultaneous determination for pharmaceutical quality control, stability assessment, and analytical characterization. Methodology: A rapid UHPLC–ESI–MS/MS method was developed using an...